PDCD1 and gastric cancer: Anti-PD-1 inhibitors have been officially approved for clinical use in multiple cancers (4), and in recent years, chemotherapy combined with immunotherapy has become a standard regimen for many patients with advanced gastric cancer in clinical practice.